Impact of POR and Cytochrome b5 Variability on the Genotype-Phenotype Discordance of CYP2A6 and CYP2D6: A Quantitative Analysis in Chinese Human Livers

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Drug Metabolism And Disposition

• Publication date

  2026-03-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.dmd.2026.100264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver microsomal protein content and activity in patients with hepatocellular carcinoma and cirrhosis: implications for the in vivo prediction of individual hepatic clearance

  2025cited by this paper
• Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review

  2024cited by this paper
• PharmVar GeneFocus: CYP2A6

  2024cited by this paper
• Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis

  2024cited by this paper
• Advancing CYP2D6 Pharmacogenetics through a Pharmacoequity Lens

  2023cited by this paper
• Phenotypic Models of Drug–Drug‐Gene Interactions Mediated by Cytochrome Drug‐Metabolizing Enzymes

  2023cited by this paper
• Genotype-guided model significantly improves accuracy of tacrolimus initial dosing after liver transplantation

  2022cited by this paper
• Drug metabolic enzyme genotype-phenotype discrepancy: High phenoconversion rate in patients treated with antidepressants.

  2022cited by this paper
• Han Chinese specific cytochrome P450 polymorphisms and their impact on the metabolism of anti-hypertensive drugs with adrenoreceptor blocking properties

  2021cited by this paper
• Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data

  2021cited by this paper
• Structural insights into understudied human cytochrome P450 enzymes.

  2021cited by this paper
• PharmVar GeneFocus: CYP2C9

  2021cited by this paper
• StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes

  2021cited by this paper
• Genetic and phenotypic frequency distribution of CYP2C9, CYP2C19 and CYP2D6 in over 3200 Han Chinese

  2020cited by this paper
• Variation in the expression of cytochrome P450-related miRNAs and transcriptional factors in human livers: Correlation with cytochrome P450 gene phenotypes.

  2020cited by this paper
• How precise is quantitative prediction of pharmacokinetic effects due to drug-drug interactions and genotype from in vitro data? A comprehensive analysis on the example CYP2D6 and CYP2C19 substrates.

  2020cited by this paper
• PharmVar GeneFocus: CYP2C19

  2020cited by this paper
• Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs

  2020cited by this paper
• From Genotype to Phenotype: Content and Activities of Cytochromes P450 2A6 in Human Liver In Vitro and Predicted In Vivo

  2019cited by this paper
• Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy

  2019cited by this paper
• Influences of cytochrome b5 expression and its genetic variant on the activity of CYP2C9, CYP2C19 and CYP3A4.

  2019cited by this paper
• PharmVar GeneFocus: CYP2D6

  2019cited by this paper
• Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype prediction

  2018cited by this paper
• CYP2D6 Genotype Phenotype Discordance Due to Drug‐Drug Interaction

  2018cited by this paper
• Content and Activities of UGT2B7 in Human Liver In Vitro and Predicted In Vivo: A Bottom-Up Approach

  2018cited by this paper
• CYP3A4/5 Activity Probed with Testosterone and Midazolam: Correlation between Two Substrates at the Microsomal and Enzyme Levels.

  2018cited by this paper
• From Genotype to Phenotype: Cytochrome P450 2D6-Mediated Drug Clearance in Humans.

  2017cited by this paper
• Correlation of Cytochrome P450 Oxidoreductase Expression with the Expression of 10 Isoforms of Cytochrome P450 in Human Liver

  2016cited by this paper
• Gene polymorphisms and contents of cytochrome P450s have only limited effects on metabolic activities in human liver microsomes.

  2016cited by this paper
• Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach

  2016cited by this paper
• Physiological Content and Intrinsic Activities of 10 Cytochrome P450 Isoforms in Human Normal Liver Microsomes

  2016cited by this paper
• Prediction of CYP2D6 phenotype from genotype across world populations

  2016cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel

  2015cited by this paper
• An Individual-Centered Framework For Unravelling Genotype-Phenotype Interactions.

  2015cited by this paper
• Interindividual variability of CYP2C19-catalyzed drug metabolism due to differences in gene diplotypes and cytochrome P450 oxidoreductase content

  2015cited by this paper
• Content and activity of human liver microsomal protein and prediction of individual hepatic clearance in vivo

  2015cited by this paper
• Effect of Cytochrome b5 Content on the Activity of Polymorphic CYP1A2, 2B6, and 2E1 in Human Liver Microsomes

  2015cited by this paper
• Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

  2014cited by this paper
• Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

  2013cited by this paper
• Beyond genotype to phenotype: why the phenotype of an individual cannot always be predicted from their genome sequence and the environment that they experience

  2012cited by this paper
• In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods.

  2012cited by this paper
• Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs.

  2012cited by this paper
• The corrected traditional equations for calculation of hepatic clearance that account for the difference in drug ionization in extracellular and intracellular tissue water and the corresponding corrected PBPK equation.

  2011cited by this paper
• Associations of CYP2A6 genotype with smoking behaviors in southern China.

  2011cited by this paper
• Prediction of Human Metabolic Clearance from In Vitro Systems: Retrospective Analysis and Prospective View

  2010cited by this paper
• Measurement of cytochrome P450 and NADPH–cytochrome P450 reductase

  2009cited by this paper
• P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity

  2008cited by this paper
• CYP2A6 polymorphisms in Malays, Chinese and Indians

  2006cited by this paper
• A novel single nucleotide polymorphism altering stability and activity of CYP2a6.

  2001cited by this paper
• Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism

  1999cited by this paper

• No citing papers are available for this paper.